Jin Cui - Cansino Biologics Board Secretary
| 688185 Stock | 61.23 0.13 0.21% |
Executive
Jin Cui is Board Secretary of Cansino Biologics
| Age | 37 |
| Address | 401-420, Biomedical Park, Tianjin, China, 300457 |
| Phone | 86 022 5821 3600 |
| Web | https://www.cansinotech.com |
Cansino Biologics Management Efficiency
The company has return on total asset (ROA) of (0.0792) % which means that it has lost $0.0792 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1362) %, meaning that it generated substantial loss on money invested by shareholders. Cansino Biologics' management efficiency ratios could be used to measure how well Cansino Biologics manages its routine affairs as well as how well it operates its assets and liabilities. At present, Cansino Biologics' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 481.5 M, whereas Total Assets are forecasted to decline to about 6.7 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Ying Yuan | China Life Insurance | 46 | |
| Chong Xing | PetroChina Co Ltd | N/A | |
| Walter Brandstaetter | China Construction Bank | N/A | |
| Gang Wu | Agricultural Bank of | 59 | |
| Jiandong Liu | Bank of China | 55 | |
| FCS FCIS | China Construction Bank | 47 | |
| Lei Zhang | PetroChina Co Ltd | N/A | |
| Yan Liu | Bank of China | N/A | |
| Changmiao Hu | China Construction Bank | 60 | |
| Sun Jianping | Ping An Insurance | 63 | |
| Wei Fang | PetroChina Co Ltd | N/A | |
| Chongmiao Xu | China Life Insurance | 55 | |
| Jiajin Lyu | Industrial Bank Co | 56 | |
| Jiajin Lv | Industrial Bank Co | 56 | |
| Guoli Tian | China Construction Bank | 64 | |
| Daofeng Lin | Shanghai Pudong Development | N/A | |
| Sau Ng | Agricultural Bank of | N/A | |
| Panshi Jin | China Construction Bank | 59 | |
| Di Zhang | China Life Insurance | 56 | |
| Guoqiang Han | Agricultural Bank of | 57 | |
| Xueqing Guan | Industrial and Commercial | 61 | |
Management Performance
| Return On Equity | -0.14 | ||||
| Return On Asset | -0.0792 |
Cansino Biologics Leadership Team
Elected by the shareholders, the Cansino Biologics' board of directors comprises two types of representatives: Cansino Biologics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cansino. The board's role is to monitor Cansino Biologics' management team and ensure that shareholders' interests are well served. Cansino Biologics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cansino Biologics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yonghui Wu, Vice Marketing | ||
| Jin Cui, Board Secretary | ||
| Xuefeng Yu, Chairman, CoFounder | ||
| Tao Zhu, Deputy CoFounder | ||
| Chunlin Xin, Director Department | ||
| Xi Luo, Chief Officer | ||
| FCS FCIS, Joint Secretary | ||
| Dongxu MBA, Executive CoFounder | ||
| Jing Wang, Deputy Officer | ||
| ShouBai Chao, COO Director |
Cansino Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cansino Biologics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.14 | ||||
| Return On Asset | -0.0792 | ||||
| Profit Margin | (0.96) % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 9.47 B | ||||
| Shares Outstanding | 114.78 M | ||||
| Shares Owned By Insiders | 62.90 % | ||||
| Shares Owned By Institutions | 3.68 % | ||||
| Price To Book | 3.00 X | ||||
| Price To Sales | 14.40 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Cansino Stock
Cansino Biologics financial ratios help investors to determine whether Cansino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cansino with respect to the benefits of owning Cansino Biologics security.